查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771757

药物研发外包市场规模、份额和趋势分析报告：按工作流程、药物、服务、治疗领域、最终用途、地区和细分市场进行预测，2025 年至 2033 年

Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Drug, By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

药物研发外包市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球药物研发外包市场规模预计到 2033 年将达到 171.1 亿美元，2025 年至 2033 年的复合年增长率为 9.83%。新冠疫情 (COVID-19) 大流行使製药公司备受关注。药物研发是一个成本高且耗时的过程。因此，製药和生物技术公司选择将其研究活动外包给学术机构和私人公司(CRO)。公营和私营公司之间日益增多的合作正在加速药物研发进程，从而导致全球对药物研发外包服务的需求增加。

预计这种情况将在新冠疫情后持续下去。慢性疾病患者的增加给企业带来了开发延长寿命药物的压力。根据联合国估计，2015年至2020年期间，65岁及以上人口的预期寿命预计将再增加17年。企业积极寻求外包的主要治疗领域包括癌症、循环系统和抗感染药感染疾病。 2020年11月，Astra Zeneca与九家领先的癌症医疗中心合作，以加强对一些最难治疗癌症的研究。该公司计划资助该网路成员的临床和非临床研究提案。

新冠疫情彰显了药物研发的价值。全球人民翘首以盼疫苗问世之际，多家公司正积极研发有效疫苗对抗新冠疫情。辉瑞公司和BioNTech SE公司研发的疫苗，在针对一种可对抗新冠病毒的病毒株进行第三期临床试验后，获得了全球首个核准。临床试验方面，许多临床试验已暂停，但部分临床试验正在透过远端监控技术进行。因此，疫情将製药业推向了风口浪尖，药物研发外包成为开发有效抗病毒治疗方法的关键环节。因此，预计未来两年，药物研发外包将作为短期繁荣推动市场收益成长，之后将恢復其原有的成长曲线。

药物研发外包市场报告重点

  • 由于治疗目标日益复杂、研发成本不断上升以及内部资源有限的生物技术公司产品线不断扩大，预计全球药物研发外包市场将在预计期间快速成长。
  • 药物研发外包产业根据计划复杂性、风险分担安排和客户需求采用各种定价模式。
  • 2024年，基于工作流程细分，先导化合物识别和候选化合物优化细分占据市场的最大收入份额。
  • 根据药物类型，预计小分子药物将在 2024 年的预测期内占据最大份额。
  • 根据服务领域，市场分为化学服务和生物服务。
  • 根据治疗领域，呼吸系统将在 2024 年占据最大的市场占有率。
  • 根据最终用途，製药和生物技术公司在 2024 年占据最大的市场占有率。
  • 2024年，北美占全球最大销售份额，为41.16%。

目录

第一章调查方法与范围

第二章执行摘要

第三章药物研发外包市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 定价模式分析
  • 技术格局
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章药物研发外包市场：工作流程评估与趋势分析

  • 药物研发外包市场（依工作流程）：细分仪表板
  • 药物研发外包市场（依工作流程）：变异分析
  • 按工作流程，2021-2033 年
  • 目标识别与筛检
  • 目标检验和功能资讯科学
  • 潜在客户资格审查和候选人优化
  • 临床前开发
  • 其他的

第五章药物研发外包市场：药物估值与趋势分析

  • 药物研发外包市场（按药物）：细分仪表板
  • 药物研发外包市场（按药物）：差异分析
  • 依药物分类，2021-2033 年
  • 小分子
  • 高分子

第六章药物研发外包市场：服务评估与趋势分析

  • 药物研发外包市场（按服务）：细分仪表板
  • 药物研发外包市场（按服务）：波动分析
  • 按服务划分，2021-2033 年
  • 化学服务
  • 生物服务

第七章药物研发外包市场：治疗领域估计与趋势分析

  • 药物研发外包市场（依治疗领域）：细分仪表板
  • 药物研发外包市场（依治疗领域）：波动分析
  • 依治疗领域，2021-2033年
  • 呼吸系统
  • 疼痛和麻醉
  • 肿瘤学
  • 眼科
  • 血液学
  • 心血管系统
  • 内分泌
  • 胃肠道
  • 免疫调节
  • 抗感染
  • 中枢神经系统
  • 皮肤科
  • 泌尿生殖系统

第八章：药物研发外包市场：最终用途估计与趋势分析

  • 药物研发外包市场（依最终用途）：细分仪表板
  • 药物研发外包市场（依最终用途）：差异分析
  • 按应用，2021-2033 年
  • 製药和生物技术公司
  • 学术机构

第九章药物研发外包市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2033 年区域市场占有率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Albany Molecular Research Inc.
    • EVOTEC
    • Laboratory Corporation of America Holdings
    • GenScript
    • Charles River Laboratories
    • WuXi AppTec
    • Thermo Fisher Scientific Inc.
    • Dalton Pharma Services
    • Oncodesign
    • Jubilant Biosys
    • DiscoverX Corp.
    • QIAGEN
    • Eurofins SE
    • Syngene International Limited
    • Dr. Reddy Laboratories Ltd.
    • Pharmaron Beijing Co., Ltd.
    • TCG Lifesciences Pvt Ltd.
    • Domainex Ltd.
Product Code: GVR-2-68038-392-8

Drug Discovery Outsourcing Market Growth & Trends:

The global drug discovery outsourcing market size is expected to reach USD 17.11 billion by 2033 and is expected to expand at a CAGR of 9.83% from 2025 to 2033, according to a new report by Grand View Research, Inc. The COVID-19 pandemic has brought pharmaceutical companies in limelight. Drug discovery is a costly and lengthy process. This has urged pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Rising partnerships between public or private entities accelerate drug discovery processes, which, in turn, increase the global demand for outsourcing services for drug discovery.

This scenario is expected to sustain post-Covid implications as well. A rise in cases of chronic diseases has urged companies to develop medicines that extend life expectancy. According to the United Nations, people aged 65 years between 2015 and 2020 are expected to live an additional 17 years. Some of the key therapeutic areas where companies are actively involved in outsourcing include oncology, cardiovascular, and anti-infectives. In November 2020, AstraZeneca collaborated with 9 of the foremost oncology medical centers to expedite research in some of the hardest-to-treat cancers. The company will be funding clinical and non-clinical research proposals from members of this network.

The COVID-19 pandemic has demonstrated the value of drug discovery and development. People across the world are waiting for a vaccine while several companies are proactively involved in developing an effective vaccine to combat COVID-19. Pfizer Inc. and BioNTech SE received first approval for the vaccine following a worldwide Phase 3 trial of a potential strain to combat the virus. As for clinical trials, many of them are halted, while some are functional by adopting remote monitoring technologies. Thus, the pandemic has brought the pharmaceutical industry to center stage with drug discovery outsourcing becoming a key aspect to develop effective treatments against the virus. This is expected to boost the market revenue for the next 2 years i.e. a short-term boom, after which it shall regain its original growth curve.

Drug Discovery Outsourcing Market Report Highlights:

  • The global market is expected to witness rising growth over the estimated time, fueled by the increasing complexity of therapeutic targets, rising research and development costs, and a growing pipeline of biotech companies with limited internal resources.
  • The drug discovery outsourcing industry utilizes various pricing models for project complexity, risk-sharing arrangements, and client needs.
  • In 2024, the lead identification and candidate optimization segment held the largest revenue share in the market based on the workflow segment.
  • Based on the drug type segment, the small molecules segment accounted for the largest share in 2024 during the forecast period.
  • Based on service segment, the market is segmented into chemistry services and biology services.
  • Based on the therapeutics area segment, the respiratory system segment accounted for the largest market share in 2024.
  • Based on the end use segment, the pharmaceutical & biotechnology companies segment accounted for the largest market share in 2024.
  • In 2024, North America held the largest revenue share of 41.16% globally.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Drug
    • 1.2.3. Service
    • 1.2.4. Therapeutics Area
    • 1.2.5. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing R&D In the Biopharmaceutical Industry
      • 3.2.1.2. Increasing demand for outsourcing Services in Drug Development
      • 3.2.1.3. Increasing number of partnerships in drug discovery research
      • 3.2.1.4. Technological advancements in drug discovery
      • 3.2.1.5. Rising incidence rate of metabolic, genetic, and other chronic diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of open-source software packages for drug discovery
      • 3.2.2.2. High manufacturing costs coupled with a high risk of drug failure
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Drug Discovery Outsourcing Market: Drug Estimates & Trend Analysis

  • 5.1. Drug Discovery Outsourcing Market, By Drug: Segment Dashboard
  • 5.2. Drug Discovery Outsourcing Market, By Drug: Movement Analysis
  • 5.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Drug, 2021 - 2033 (USD Million)
  • 5.4. Small Molecules
    • 5.4.1. Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Large Molecules
    • 5.5.1. Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 6.1. Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 6.2. Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 6.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 6.4. Chemistry Services
    • 6.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biology Services
    • 6.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 7.1. Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 7.2. Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 7.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
  • 7.4. Respiratory system
    • 7.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Pain and Anesthesia
    • 7.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Oncology
    • 7.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Ophthalmology
    • 7.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Hematology
    • 7.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Cardiovascular
    • 7.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Endocrine
    • 7.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.11. Gastrointestinal
    • 7.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.12. Immunomodulation
    • 7.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.13. Anti-infective
    • 7.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.14. Central Nervous System
    • 7.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.15. Dermatology
    • 7.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.16. Genitourinary System
    • 7.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 8.1. Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 8.2. Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 8.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology companies
    • 8.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Academic Institutes
    • 8.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Dashboard
  • 9.2. Regional Market Share Analysis, 2024 & 2033
  • 9.3. North America
    • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Australia
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Share/Assessment Analysis, 2024
  • 10.3. Company Profiles
    • 10.3.1. Albany Molecular Research Inc.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Service Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. EVOTEC
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Service Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Laboratory Corporation of America Holdings
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Service Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. GenScript
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Service Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Charles River Laboratories
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Service Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. WuXi AppTec
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Service Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. Thermo Fisher Scientific Inc.
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Service Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. Dalton Pharma Services
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Service Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. Oncodesign
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Service Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Jubilant Biosys
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Service Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. DiscoverX Corp.
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Service Benchmarking
      • 10.3.11.4. Strategic Initiatives
    • 10.3.12. QIAGEN
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Financial Performance
      • 10.3.12.3. Service Benchmarking
      • 10.3.12.4. Strategic Initiatives
    • 10.3.13. Eurofins SE
      • 10.3.13.1. Company Overview
      • 10.3.13.2. Financial Performance
      • 10.3.13.3. Service Benchmarking
      • 10.3.13.4. Strategic Initiatives
    • 10.3.14. Syngene International Limited
      • 10.3.14.1. Company Overview
      • 10.3.14.2. Financial Performance
      • 10.3.14.3. Service Benchmarking
      • 10.3.14.4. Strategic Initiatives
    • 10.3.15. Dr. Reddy Laboratories Ltd.
      • 10.3.15.1. Company Overview
      • 10.3.15.2. Financial Performance
      • 10.3.15.3. Service Benchmarking
      • 10.3.15.4. Strategic Initiatives
    • 10.3.16. Pharmaron Beijing Co., Ltd.
      • 10.3.16.1. Company Overview
      • 10.3.16.2. Financial Performance
      • 10.3.16.3. Service Benchmarking
      • 10.3.16.4. Strategic Initiatives
    • 10.3.17. TCG Lifesciences Pvt Ltd.
      • 10.3.17.1. Company Overview
      • 10.3.17.2. Financial Performance
      • 10.3.17.3. Service Benchmarking
      • 10.3.17.4. Strategic Initiatives
    • 10.3.18. Domainex Ltd.
      • 10.3.18.1. Company Overview
      • 10.3.18.2. Financial Performance
      • 10.3.18.3. Service Benchmarking
      • 10.3.18.4. Strategic Initiatives

List of Tables

  • Table 1. List of Tables
  • Table 2. List of Secondary Sources
  • Table 3. List of Abbreviations
  • Table 4. Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 5. Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 6. Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 7. Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 8. Global Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 9. Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 10. North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 11. North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 12. North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 13. North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14. North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 15. North America Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16. U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 17. U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 18. U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 19. U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 20. U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 21. Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 22. Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 23. Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24. Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 25. Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 26. Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 27. Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 28. Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 29. Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 30. Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 31. Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 32. Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 33. Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 34. Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 35. Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 36. Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 37. UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 38. UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 39. UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40. UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 41. UK Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 42. Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 43. Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 44. Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45. Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 46. Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 47. France Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 48. France Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 49. France Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 50. France Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 51. France Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 52. Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 53. Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 54. Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 55. Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 56. Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57. Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 58. Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 59. Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 60. Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 61. Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 62. Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 63. Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 64. Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65. Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 66. Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 67. Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 68. Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 69. Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 70. Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 71. Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 72. Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 73. Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 74. Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 75. Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 76. Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 77. Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 78. Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 79. Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 80. Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81. Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 82. Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83. Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 84. Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 85. Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 86. Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 87. Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 88. China Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 89. China Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 90. China Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 91. China Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 92. China Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 93. India Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 94. India Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 95. India Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 96. India Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 97. India Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 98. Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 99. Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 100. Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 101. Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 102. Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 103. South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 104. South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 105. South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 106. South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 107. South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 108. Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 109. Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 110. Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 111. Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 112. Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 113. Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 114. Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 115. Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 116. Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 117. Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 118. Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 119. Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 120. Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 121. Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 122. Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 123. Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 124. Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 125. Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 126. Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 127. Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 128. Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 129. Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 130. Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 131. Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 132. Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 133. Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 134. Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 135. South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 136. South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 137. South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 138. South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 139. South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 140. Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 141. Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 142. Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 143. Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 144. Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 145. UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 146. UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 147. UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 148. UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 149. UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 150. Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 151. Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 152. Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 153. Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 154. Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Drug Discovery Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
  • Fig. 20 Drug Discovery Outsourcing Market: Workflow movement analysis
  • Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Drug Discovery Outsourcing Market: Drug outlook and key takeaways
  • Fig. 27 Drug Discovery Outsourcing Market: Drug movement analysis
  • Fig. 28 Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Drug Discovery Outsourcing Market: Service outlook and key takeaways
  • Fig. 31 Drug Discovery Outsourcing Market: Service movement analysis
  • Fig. 32 Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
  • Fig. 35 Drug Discovery Outsourcing Market: Therapeutics Area Movement Analysis
  • Fig. 36 Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Drug Discovery Outsourcing Market: End Use outlook and key takeaways
  • Fig. 50 Drug Discovery Outsourcing Market: End Use Movement Analysis
  • Fig. 51 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Regional Marketplace: Key Takeaways
  • Fig. 54 North America Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 MEA Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key company categorization
  • Fig. 106 Service heat map analysis
  • Fig. 107 Strategic framework